تعزز قدرة الاستيراد السنوية للمكتب العلمي البالغ 23 مليون دولار على قيادة السوق في العراق
Baghdad, Iraq – Pharma Scientific Bureau has cemented its position as Iraq’s premier pharmaceutical distributor with a $23 million USD annual import capacity, enabling unmatched access to high-quality medicines from global manufacturers. This financial strength powers the company’s nationwide distribution network, serving over 5,000 pharmacies and 200+ hospitals across all Iraqi regions.
Key Drivers of Market Leadership
Global Supplier Network
- Direct partnerships with 50+ manufacturers from FDA/EMA-approved facilities in:
✓ Europe: Germany, France, Switzerland
✓ North America: USA, Canada
✓ Asia: Japan, UAE (Gulf region) - Specialized imports of biologics, vaccines, and specialty drugs (20% portfolio growth in 2023).
Infrastructure Investments
$4.2M allocated in 2023 to:
✓ Expand Baghdad Central Warehouse (now 12,000 sqm with 8 cold rooms)
✓ Deploy IoT temperature loggers across all shipments
✓ Upgrade Erbil/Basra facilities to WHO GDP standards
Financial Reliability
- Zero payment delays to suppliers since 2020 (per audited records)
- Letter of Credit (LC) financing secured through 5 international banks
Operational Impact
- 48-hour restocking for 90% of essential medicines
- 15% cost reduction for hospitals via bulk procurement
- First-to-market access to 12+ breakthrough therapies in 2024
Why It Matters
This import capacity allows Pharma to:
✔ Prevent shortages during Iraq’s currency fluctuations
✔ Negotiate better pricing vs. smaller competitors
✔ Attract premium partners (e.g., recent Novartis Iraq distribution deal)
